| 1) were recorded, using a 3D Motion Analysis System. |
| 2) return with negative impact over the eco-system. |
| 3) llenge for the patient and their support system. |
| 4) SICs) are widely expressed in the nervous system. |
| 5) nd diverse effects on the central nervous system. |
| 6) edicine to patient care across our health system. |
| 7) ones also including the thalamo-cortical system. |
| 8) nervous system, the skin, and the immune system. |
| 9) se has important effects on the glutamate system. |
| 10) of tissues, including the musculoskeletal system. |
| 11) tions and lacks a consistent risk grading system. |
| 12) PA using an M13 filamentous phage display system. |
| 13) bserved by an under-oil open microfluidic system. |
| 14) nsurance programs, or a public healthcare system. |
| 15) ation in agriculture and the broader food system. |
| 16) g the strong T7 RNA polymerase expression system. |
| 17) usly overrepresented in the child welfare system. |
| 18) irectly impairs functioning of the immune system. |
| 19) otein 9 (Cas9) (CRISPR/Cas9) gene-editing system. |
| 20) sease, with the IVD as an exemplar tissue system. |
| 21) or the development and maintenance of the system. |
| 22) to more aspects of health and the health system. |
| 23) oward the global burden on the healthcare system. |
| 24) play crucial roles in the central nervous system. |
| 25) anguage Language Association (ASHA)'s LOE system. |
| 26) ystemic lupus erythematosus in the visual system. |
| 27) ble diet that promotes a sustainable food system. |
| 28) e widely expressed in the central nervous system. |
| 29) say, illustrating the limitations of this system. |
| 30) patients in a large health care delivery system. |
| 31) C staff had positive perceptions with the system. |
| 32) ing tumor cells while alerting the immune system. |
| 33) nergic equilibrium in the central nervous system. |
| |